Monday, November 11, 2024
HomeTagsFirst Targeted

First Targeted

Novartis Pluvicto Approved by FDA as First Targeted Radioligand Therapy

Novartis announced today that the US Food and Drug Administration (FDA) approved Pluvicto™ (lutetium Lu 177 vipivotide tetraxetan) (formerly referred to as 177Lu-PSMA-617) for...

Fusion Pharmaceuticals Announces Nomination of First Targeted Alpha Therapy Candidate in Collaboration with AstraZeneca

Fusion Pharmaceuticals Inc., a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, announced nomination of the first targeted alpha therapy (TAT)...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics